行情

OMCL

OMCL

Omnicell
NASDAQ

实时行情|Nasdaq Last Sale

73.83
+1.74
+2.41%
交易中 12:58 11/14 EST
开盘
72.35
昨收
72.09
最高
74.04
最低
72.06
成交量
4.64万
成交额
--
52周最高
92.59
52周最低
56.96
市值
30.96亿
市盈率(TTM)
58.13
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

OMCL 新闻

  • 美国消费者舒适度指数创下2008年以来最大三周降幅
  • 新浪美股.2小时前
  • 苹果罕见被评为“卖出” Maxim不看好iPhone销售
  • 新浪美股.2小时前
  • 美国预算赤字将达万亿 经济衰退或不可避免
  • 新浪财经-自媒体综合.2小时前
  • 传苹果明年推“超级捆绑包” 整合多项付费服务
  • 新浪科技.3小时前

更多

所属板块

先进医疗设备和技术
+0.25%
医疗设备和用品
+0.17%

热门股票

名称
价格
涨跌幅

OMCL 简况

Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication and supply dispensing systems, pharmacy inventory management systems and related software. The Medication Adherence segment includes the development, manufacturing and selling of consumable medication blister cards, packaging equipment, medication synchronization platform, and ancillary products and services. Its products are used to manage medication administration outside of the hospital setting and include medication adherence products sold under the brand name MTS, Surgichem, SureMed and the Omnicell brand.
展开

Webull提供Omnicell, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。